Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cellular Immunology

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CELLIMM.2007.07.003PMID 17707782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice.

  2007cited by this paper
• The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

  2006cited by this paper
• Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.

  2006cited by this paper
• Virus-like particles: Passport to immune recognition

  2006cited by this paper
• Cytokine Induction by the Hepatitis B Virus Capsid in Macrophages Is Facilitated by Membrane Heparan Sulfate and Involves TLR2

  2005cited by this paper
• Efficient homologous prime‐boost strategies for T cell vaccination based on virus‐like particles

  2005cited by this paper
• Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting.

  2005cited by this paper
• Universal influenza A vaccine: optimization of M2-based constructs.

  2005cited by this paper
• A "universal" human influenza A vaccine.

  2004cited by this paper
• Tumour escape from immune surveillance through dendritic cell inactivation.

  2002cited by this paper
• Soluble recombinant influenza vaccines.

  2001cited by this paper
• Expression and Immunogenicity of Human Immunodeficiency Virus Type 1 Gag Expressed by a Replication-Competent Rhabdovirus-Based Vaccine Vector

  2001cited by this paper
• HBV Core Particles as a Carrier for B Cell/T Cell Epitopes

  2001cited by this paper
• Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells1

  2001cited by this paper
• Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered with Escherichia coli Heat-Labile Enterotoxin Mutant R192G or CpG DNA

  2001cited by this paper
• Efficient Particle Production by Minimal Gag Constructs Which Retain the Carboxy-Terminal Domain of Human Immunodeficiency Virus Type 1 Capsid-p2 and a Late Assembly Domain

  2000cited by this paper
• T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles.

  1998cited by this paper
• Application of the Human Hepatitis B Virus Core Antigen from Transgenic Tobacco Plants for Serological Diagnosis

  1998cited by this paper
• Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.

  1996cited by this paper
• Hepatitis B virus core particles as epitope carriers.

  1995cited by this paper
• Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly.

  1995cited by this paper
• Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

  1995cited by this paper
• Expression and characterization of virus-like particles containing rubella virus structural proteins

  1994cited by this paper
• Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.

  1994cited by this paper
• The influence of antigen organization on B cell responsiveness.

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• Expression of hepatitis B core antigen gene in recombinant vaccinia virus.

  1989cited by this paper
• The secretory core protein of human hepatitis B virus is expressed on the cell surface

  1989cited by this paper
• Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

  1987cited by this paper
• Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons

  1986cited by this paper
• Expression of hepatitis B viral antigens in animal cells transfected with viral DNA.

  1982cited by this paper
• Expression of cloned hepatitis B virus DNA in human cell cultures.

  1980cited by this paper

• Recombinant Chimeric Virus-like Particles of Human Papillomavirus Produced by Distinct Cell Lineages: Potential as Prophylactic Nanovaccine and Therapeutic Drug Nanocarriers

  2025cites this paper
• VLP (Virus-Like Particles) Vaccines - Current Knowledge and Future Directions

  2025cites this paper
• Engineering Escherichia coli-Derived Nanoparticles for Vaccine Development

  2024cites this paper
• Experimental and molecular dynamics simulation studies on the physical properties of three HBc-VLP derivatives as nanoparticle protein vaccine candidates.

  2024cites this paper
• Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform

  2024cites this paper
• Viral nanoparticles: Current advances in design and development.

  2023cites this paper
• Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy

  2023cites this paper
• Process monitoring framework for cross‐flow diafiltration‐based virus‐like particle disassembly: Tracing product properties and filtration performance

  2022cites this paper
• Chimeric virus-like particles presenting tumour-associated MUC1 epitope result in high titers of specific IgG antibodies in the presence of squalene oil-in-water adjuvant: towards safe cancer immunotherapy

  2022cites this paper
• Hepatitis B core-based virus-like particles: A platform for vaccine development in plants

  2021cites this paper
• Cost‐effective purification process development for chimeric hepatitis B core (HBc) virus‐like particles assisted by molecular dynamic simulation

  2021cites this paper
• Covalent protein display on Hepatitis B core-like particles in plants through the in vivo use of the SpyTag/SpyCatcher system

  2020cites this paper
• Development of HBc virus-like particles as modular nanocarrier by intein-mediated trans-splicing.

  2020cites this paper
• Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy

  2019cites this paper
• Virus‐like particles for vaccination against cancer

  2019cites this paper
• Cell-permeable capsids as universal antigen carrier for the induction of an antigen-specific CD8+ T-cell response

  2017cites this paper
• Virus like particles as a platform for cancer vaccine development

  2017influential citation
• A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles

  2016cites this paper
• A Potential In Silico Designed Chimeric Antigen for Precise Screening of HTLV-I and HTLV-II

  2016cites this paper
• Expression and Purification of a Novel Computationally Designed Antigen for Simultaneously Detection of HTLV-1 and HBV Antibodies.

  2015cites this paper
• Development of therapeutic vaccine strategies and pre-clinical animal tumor models for head and neck cancers

  2015cites this paper
• Hepatitis B core–based virus–like particles to present heterologous epitopes

  2013cites this paper
• VLPs and particle strategies for cancer vaccines

  2013cites this paper
• Novel vaccination strategies against human respiratory syncytial virus

  2013cites this paper
• Fluorosomes: Fluorescent Virus-Like Nanoparticles that Represent a Convenient Tool to Visualize Receptor-Ligand Interactions

  2013cites this paper
• Human parvovirus B19 virus-like particles: In vitro assembly and stability.

  2012cites this paper
• Agent d'induction de cellule t cytolytique

  2012cites this paper
• Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases.

  2011cites this paper
• Significant anti‐tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8+ T cell/regulatory T cells in tumour

  2010cites this paper
• Cancer–germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment

  2010cites this paper
• A preliminary study on the activation and antigen presentation of hepatitis B virus core protein virus-like particle-pulsed bone marrow-derived dendritic cells.

  2010cites this paper
• Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.

  2009cites this paper
• The use of small peptides in the diagnosis and treatment of hepatocellular carcinoma.

  2009cites this paper
• Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect.

  2009cites this paper
• Promising particle-based vaccines in cancer therapy

  2008cites this paper